HPV 16 detection in cervical lesions, physical state of viral DNA and changes in p53 gene
Keywords:
HPV, Viral, DNA, Integration, Gene, Cervical, LesionsAbstract
CONTEXT: Persistent infection with high risk human papillomavirus (HPV) has been linked to cervical carcinoma. Integration of viral DNA into host cell DNA is essential for this cancer development, promoting disruption of the HPV E2 gene, thus leading to unregulated increases in E6 and E7 proteins and inactivating the products of p53 and Rb tumor suppressor genes. OBJECTIVE: To investigate HPV 16 infection in cervical lesions, physical state of viral DNA and p53 gene alterations in a group of women attending a public health service. DESIGN: Prospective, non-controlled, transversal study. SETTING: Gynecological clinic of the School od Medicine, Universidade Federal Fluminense. SAMPLE: 43 consective patients with cervical lesions referred to our service. MAIN MEASUREMENTS: Cases were classified via cytology/histology as normal, HPV infection, condyloma, low-grade squamous intraepithelial lesion (LSIL), high-grade squamous intraepithelial lesion (HSIL) and carcinoma. HPV infection was studied via polymerase chain reaction (PCR) using two PCR primer sets, to determine DNA integration. p53 gene changes were investigated by single-strand conformation polymorphism (SSCP) analysis. RESULTS: One normal case, 7 HPV infections, 6 condylomas, 7 LSIL, 14 HSIL and 8 cancers were found, with 95% positive for HPV genome when tested using both L1 and E6 primers. HPV 16 was most prevalent (73.1%). HPV 16 DNA was integrated within the host genome in 3 LSIL. One LSIL progressed to HSIL by 13 months after first diagnosis. Among HPV 16-positive HSIL cases, 50% contained integrated viral DNA. HPV 16 E2 gene disruption was seen in 7 cancers (87.5%). Only smal-cell carcinoma showed intact HPV 16 E2 gene. Abnormal p53 bands detected by PCR/SSCP were observed in 4 cases: 2 squamous carcinoma with parametrium (exon 8) and two cervical intraepithelial neoplasia (CIN) III (exons 5 and 7). All cases presented HPV 16 E2 gene loss. CONCLUSIONS: The sample had a high rate of highrisk HPV detected in benign and malignant lesions; high cervical cancer burden; HPV 16 DNA integration in all except one case of cancer; p53 gene changes in CIN III and in invasive cancer cases associated with DNA integration.
Downloads
References
Pisani P, Parkin DM, Bray F, Ferlay J. Estimates of the worlwide mortality from 25 cancers in 1990. Int J Cancer 1999;83(1):18-29.
Noronha V, Mello W, Villa L, et al. Papilomavírus humano associado a lesões de cérvice uterina. Rev Soc Bras Med Trop 1999; 32(3):235-40.
Lopes ER, Rebelo MS, Abreu E, Silva VLC, Eisenberg ALA, Lavor MF. Comportamento da população brasileira feminina em relação ao cancer cérvico- uterino. J Bras Ginecol 1995;105(11/12):505-15.
Haddad N, Silva MB. 2001 Mortalidade por neoplasmas em mulheres em idade reprodutiva -15 a 49 anos - no estado de São Paulo, Brasil, de 1991 a 1995. Rev Assoc Med Bras 2001;47(3):221-30.
Muñoz N. Human papillomavirus and cervical cancer. In: Franco E, Monsonego J, eds. New development in cervical can- cer screening and prevention. Cambridge: Blackwell Science, 1997.p.3-13.
Schiffman MH, Bauer HM, Hoover RN, et al. Epidemiologic evidence showing that human papillomavirus infection causes most cervical intraepithelial neoplasia. J Natl Cancer Inst 1993;85(12):958-64.
Ho GY, Bierman R, Beardsley L, Chang CJ, Burk RD. Natural history of cervicovaginal papillomavirus infection in young women. N Engl J Med 1998;338(7):423-8.
Bosch FX, Manos MM, Muñoz N, et al. Prevalence of human papillomavirus in cervical cancer: a worldwide perspective. In- ternational biological study on cervical cancer (IBSCC) Study Group. J Natl Cancer Inst 1995;87(11):796-802.
Park TW, Fugiwara H, Wright TC. Molecular biology of cervical cancer and its precursors. Cancer 1995;76(Suppl 10):1902-13.
Lane DP. Cancer. p53, guardian of the genome. Nature 1992;358(6381):15-6.
Greenblatt MS, Bennett WP, Hollstein M, Harris CC. Muta- tions in the p53 tumour suppressor gene: clues to cancer etiology and molecular pathogenesis. Cancer Res 1994;54(18):4855-78.
Bremer GL, Tieboschb AT, van der Putten HW, de Haan J, Arends JW. p53 tumor suppressor gene protein expression in cervical cancer: relationship to prognosis. Eur J Obstet Gynecol Reprod Biol 1995;63(1):55-9.
Tinos Y, Manos M. Detection and typing of genital human papillomaviruses. In: Innis M, Gelfand D, Sninsky J, White T, eds. PCR protocols: a guide to methods and application. San Diego: Academic Press 1990.p.356-67.
Park JS, Hwang ES, Park SN, Ahn HK, Um SJ, Kim CJ, Kim SJ, Namkoong SE. Physical status and expression of HPV genes in cervical cancers. Gynecol Oncol 1997;65(1):121-9.
Hildesheim A, Schiffman M, Bromley C, et al. Human papillomavirus type 16 variants and risk of cervical cancer. J Natl Cancer Inst 2001;93(4):315-8.
Mougin C, Dalstein V, Prétet JL, Gay C, Schaal JP, Riethmuller D. Epidémiologie des infections cervicales à papillomavirus. Recent Knowledge. Presse Med 2001;30(20):1017-23.
Trindade MP, Schiavo MR. Comportamento sexual das mulheres em relação ao HIVA,AIDS. DST. J Bras Doenças Sex Transm 2001;13(5):17-22.
Villa LL, Sichero L, Rahal P, et al. Molecular variants of human papillomavirus types 16 and 18 preferentially associated with cervical neoplasia. J Gen Virol 2000;81(Pt 12):2959-68
Das BC, Sharma JK, Gopalakrishna V, Luthra UK. Analysis by polymerase chain reaction of the physical state of human papillomavirus type 16 DNA in cervical preneoplastic and neoplastic lesions. J Gen Virol 1992;73(Pt 9):2327-36.
Klaes R, Woerner SM, Ridder R, et al. Detection of high-risk cervical intraepithelial neoplasia and cervical cancer by amplifi- cation of transcripts derived from integrated papillomavirus oncogenes. Cancer Res 1999;59(24):6132-6.
Nakagawa S, Yoshikawa H, Jimbo H, et al. Elderly Japanese women with cervical carcinoma show higher proportions of both intermediate-risk human papillomavirus types and p53 muta- tions. Br J Cancer 1999;79(7-8):1139-44.
